Two UM events examine timely issue of medicinal marijuana use

NewsGuard 100/100 Score

Two events this week at the University of Maryland Francis King Carey School of Law examine the timely issue of medicinal use of marijuana.

On Thursday, April 12, medical and policy experts will explore the use of marijuana as a treatment for PTSD in military veterans. Among the issues facing this group of patients are the high cost and sometimes unmanageable side effects of mainstream drugs. Panelists include Dr. Lynn McPherson of the University of Maryland School of Pharmacy, disabled veteran and drug policy expert Michael Krawitz, criminal justice expert Eric Sterling, and Maryland legislator Dr. Dan Morhaim, who is also an emergency medicine doctor and proponent of legalizing medicinal marijuana.

The event will be held from 3 p.m. to 5 p.m. at the law school, with a reception to follow.

On Friday, April 13, experts from the UM Carey School of Law and the School of Pharmacy, along with the Network for Public Health Law, present a daylong conference on "The Challenges of Implementing Medical Marijuana Laws." With 17 states and Washington, D.C., having passed laws decriminalizing the use of marijuana for medicinal purposes, the country has a patchwork of such laws. The conference will address the legal and policy issues involved, and explore the elements of a model law for the decriminalization of medical marijuana. Speakers with policy and medical backgrounds from Rhode Island to California will attend.

Source: University of Maryland Francis King Carey School of Law

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Comparing HIV PrEP medications: Study explores hypertension risk in adults on TAF vs. TDF